Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Alpha 1-Antitrypsin · Zemaira

Plasma-derived product · Protein replacement

Approved FDA, Jul 2003

What is Alpha 1-Antitrypsin?

Alpha-1 antitrypsin is a human protein encoded by the SERPINA1 gene that regulates proteolysis. It is studied in alpha-1 antitrypsin deficiency and in type 1 diabetes, including as an inhaled formulation.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Zemaira, Alpha-1 Antitrypsin
Drug type
Plasma-derived product
Mechanism
Protein replacement
Pathways
regulation of proteolysis
Therapy area
Endocrine, Metabolic
FDA status
Approved as Zemaira (July 8, 2003), BLA125078

Conditions studied

Alpha 1-Antitrypsin DeficiencyNew Onset Type-1 DiabetesType 1 Diabetes Mellitus

Sources

Updated Oct 18, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.